Adriana Manzi
President at Manzi & Associates LLC
Profile
Adriana Manzi is the President of Manzi & Associates LLC since 2006.
Prior to this, she worked as a Senior Director-Research at Baxter Healthcare Corp.
from 2001 to 2006.
She also held positions as Director-Analytical Development & Quality Control at Nextran, Director-Glycobiology Core & Assistant Professor at the University of California, and Head-Quality Assurance at Iconic Therapeutics, Inc. Dr. Manzi holds a doctorate degree from the University of California San Diego (1989) and Universidad de Buenos Aires (1984).
Adriana Manzi active positions
| Companies | Position | Start |
|---|---|---|
Manzi & Associates LLC
 Manzi & Associates LLC Miscellaneous Commercial ServicesCommercial Services Manzi & Associates LLC provides accounting services. | President | 2006-05-31 |
Former positions of Adriana Manzi
| Companies | Position | End |
|---|---|---|
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | 2005-12-31 |
| University of California | Corporate Officer/Principal | - |
Nextran
 Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Corporate Officer/Principal | - |
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Training of Adriana Manzi
| University of California San Diego | Doctorate Degree |
| Universidad de Buenos Aires | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Manzi & Associates LLC
Manzi & Associates LLC Miscellaneous Commercial ServicesCommercial Services Manzi & Associates LLC provides accounting services. | Commercial Services |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Nextran
Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Health Technology |
- Stock Market
- Insiders
- Adriana Manzi
